Financial support to assist with EYLEA cost Financial support to assist with EYLEA cost

Financial Support


EYLEA has several programs available — depending on your insurance situation — to help eligible patients with the cost of EYLEA.

EYLEA4U® OFFERS RESOURCES TO HELP

EYLEA4U is a comprehensive support program for eligible patients diagnosed with:

  • Wet Age-related Macular Degeneration (AMD)
  • Diabetic Macular Edema (DME)
  • Diabetic Retinopathy (DR) in DME
  • Macular Edema following Retinal Vein Occlusion (MEfRVO)
EYLEA4U® patient support program provides resources and financial assistance to help with EYLEA anti-VEGF treatment cost.

EYLEA Co-Pay Card Program*


Eligible patients with commercial insurance may pay as little as a $0 co-pay for each EYLEA treatment with the EYLEA Co-Pay Card. Subject to annual assistance limit.

Get co-pay card info
Get information about EYLEA's co-pay card program.

Additional financial support


If you have government insurance (like Medicare) and need help with your EYLEA out-of-pocket costs, Co-Pay Assistance Referral may be available.

The Patient Assistance Program may help eligible patients get EYLEA free of charge if you are uninsured or if your health plan doesn’t cover EYLEA.

See more details
Get information about additional financial support available to assist with the cost of EYLEA.

*Subject to annual assistance limit. Co-pay reimbursement is subject to an annual cap, and the patient is responsible for any additional co-pay costs that exceed the program assistance limit. This program is not valid for prescriptions covered by or submitted for reimbursement under Medicaid, Medicare, VA, DOD, TRICARE, or similar federal or state programs. This program is not an insurance benefit. The program does not cover or provide support for supplies, procedures, or any physician-related service associated with EYLEA. General, non–product-specific co-pay, co-insurance, or insurance deductibles are not covered. This program is not valid where prohibited by law, taxed, or restricted. EYLEA4U reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Additional program conditions apply.

†Regeneron does not influence or control the operations of independent charitable foundations and cannot guarantee assistance will be provided.

HELPFUL ADVICE

SIGN UP FOR MORE INFORMATION

Helpful resources for people living with low vision and their caregivers.

Get tips for living with low vision, what to talk with your doctor about, how to approach appointments/treatment, and more.

Sign up to receive information from EYLEA and receive a free pocket magnifier.

Get the latest materials and communications about EYLEA—and a complimentary pocket magnifier, too.

IMPORTANT SAFETY INFORMATION
  • EYLEA® (aflibercept) Injection is a prescription medicine administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.
  • Injection into the eye with EYLEA can result in an infection in the eye and retinal detachment (separation of retina from back of the eye). Inflammation in the eye has been reported with the use of EYLEA.
  • In some patients, injections with EYLEA may cause a temporary increase in eye pressure within 1 hour of the injection. Sustained increases in eye pressure have been reported with repeated injections, and your doctor may monitor this after each injection.
  • There is a potential risk of serious and sometimes fatal side effects related to blood clots, leading to heart attack or stroke in patients receiving EYLEA.
  • Serious side effects related to the injection procedure with EYLEA are rare but can occur including infection inside the eye and retinal detachment.
  • The most common side effects reported in patients receiving EYLEA are increased redness in the eye, eye pain, cataract, vitreous (gel-like substance) detachment, moving spots in the field of vision, and increased pressure in the eye.
  • It is important that you contact your doctor right away if you think you might be experiencing any side effects, including eye pain or redness, light sensitivity, or blurring of vision, after an injection.
  • EYLEA is for prescription use only. For additional safety information, please talk to your doctor and see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATIONS

EYLEA® (aflibercept) Injection is a prescription medicine approved for the treatment of patients with Wet Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR) in patients with DME.

Please see the full Prescribing Information for EYLEA.

The information contained herein is provided for general educational purposes. If you have any questions, talk to your doctor.

For U.S. Residents Only

EYLEA AND EYLEA4U are registered trademarks of Regeneron Pharmaceuticals, Inc.

© 2019, Regeneron Pharmaceuticals, Inc. All rights reserved.
777 Old Saw Mill River Road,
Tarrytown, NY 10591

12/2018
US-LEA-14281e US-LEA-14281e

 

Searching with Lea

Close
MENU